Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 1;29(2):157-164.
doi: 10.4196/kjpp.24.353. Epub 2025 Jan 14.

Neurosteroids and neurological disorders

Affiliations
Review

Neurosteroids and neurological disorders

Gi Wan Park et al. Korean J Physiol Pharmacol. .

Abstract

Neurosteroids play an important role as endogenous neuromodulators that are locally produced in the central nervous system and rapidly change the excitability of neurons and the activation of microglial cells and astrocytes. Here we review the mechanisms of synthesis, metabolism, and actions of neurosteroids in the central nervous system. Neurosteroids are able to play a variety of roles in the central nervous system under physiological conditions by binding to membrane ion channels and receptors such as gamma-aminobutyric acid type A receptors, Nmethyl- D-aspartate receptors, L- and T-type calcium channels, and sigma-1 receptors. In addition, numerous neurological disorders, including persistent neuropathic pain, multiple sclerosis, and seizures, have altered the levels of neurosteroids in the central nervous system. Thus, we review how local synthesis and metabolism of neurosteroids are modulated in the central nervous system and describe the role of neurosteroids under pathological conditions. Furthermore, we discuss whether neurosteroids may play a role as a new therapeutic for the treatment of neurological disorders.

Keywords: GABA; N-methyl-D-aspartate; Nervous system diseases; Neurosteroids; Receptors; Sigma-1 receptor.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1. Schematic diagram of the steps in the steroidogenesis of progesterone.
Cholesterol is synthesized from low density lipoprotein (LDL) by lysosomal acid lipase (LAL) or from acetyl CoA molecules. Steroidogenic acute regulatory protein (StAR) transfers cholesterol from cytoplasm into the mitochondria across the outer and inner mitochondrial membranes. Cholesterol is converted to pregnenolone by cytochrome P450side chain cleavage (P450scc), and pregnenolone is metabolized to progesterone by 3β-hydroxysteroid dehydrogenase (3β-HSD).
Fig. 2
Fig. 2. Outline of neurosteroidogenesis.
Cytochrome P450side chain cleavage (P450scc) converts cholesterol to pregnenolone, which is metabolized to progesterone by 3β-hydroxysteroid dehydrogenase (3β-HSD) or to dehydroepiandrosterone (DHEA) by cytochrome P450c17 (P450c17). Progesterone is metabolized to allopregnanolone by 5α-reductase (5α-R) and 3α-hydroxysteroid oxidoreductase (3α-HSOR) or to androstenedione by P450c17. Aromatase converts androstenedione to estrone, which is metabolized to estradiol by 17β-hydroxysteroid dehydrogenase (17β-HSD), and synthesizes estradiol from testosterone. DHP, dihydroprogesterone; DHT, dihydrotestosterone; 17-OH-PREG, 17-OH-pregnenolone; 17-OH-PROG, 17-OH-progesterone.

References

    1. Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:113–137. doi: 10.1016/B978-0-444-53630-3.00008-7. - DOI - PMC - PubMed
    1. Reddy DS, Estes WA. Clinical potential of neurosteroids for CNS disorders. Trends Pharmacol Sci. 2016;37:543–561. doi: 10.1016/j.tips.2016.04.003. - DOI - PMC - PubMed
    1. Yoon SY, Roh DH, Seo HS, Kang SY, Moon JY, Song S, Beitz AJ, Lee JH. An increase in spinal dehydroepiandrosterone sulfate (DHEAS) enhances NMDA-induced pain via phosphorylation of the NR1 subunit in mice: involvement of the sigma-1 receptor. Neuropharmacology. 2010;59:460–467. doi: 10.1016/j.neuropharm.2010.06.007. - DOI - PubMed
    1. Belelli D, Lambert JJ. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci. 2005;6:565–575. doi: 10.1038/nrn1703. - DOI - PubMed
    1. Morales-Lázaro SL, González-Ramírez R, Rosenbaum T. Molecular interplay between the sigma-1 receptor, steroids, and ion channels. Front Pharmacol. 2019;10:419. doi: 10.3389/fphar.2019.00419. - DOI - PMC - PubMed